The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Antidiabetic Agents Market Research Report 2025
Synopsis
Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
The global Oral Antidiabetic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Antidiabetic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Antidiabetic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral Antidiabetic Agents in Home Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral Antidiabetic Agents include Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Agents.
Report Scope
The Oral Antidiabetic Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Antidiabetic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Antidiabetic Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
Segment by Type
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors
Segment by Application
Home Use
Medical Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
The global Oral Antidiabetic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Antidiabetic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Antidiabetic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral Antidiabetic Agents in Home Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral Antidiabetic Agents include Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Agents.
Report Scope
The Oral Antidiabetic Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Antidiabetic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Antidiabetic Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
Segment by Type
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors
Segment by Application
Home Use
Medical Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Biguanides
1.2.5 Thiazolidinediones
1.2.6 Alpha-glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Agents Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic Agents Market Perspective (2019-2030)
2.2 Oral Antidiabetic Agents Growth Trends by Region
2.2.1 Global Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Antidiabetic Agents Historic Market Size by Region (2019-2024)
2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030)
2.3 Oral Antidiabetic Agents Market Dynamics
2.3.1 Oral Antidiabetic Agents Industry Trends
2.3.2 Oral Antidiabetic Agents Market Drivers
2.3.3 Oral Antidiabetic Agents Market Challenges
2.3.4 Oral Antidiabetic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic Agents Players by Revenue
3.1.1 Global Top Oral Antidiabetic Agents Players by Revenue (2019-2024)
3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2019-2024)
3.2 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Antidiabetic Agents Revenue
3.4 Global Oral Antidiabetic Agents Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2023
3.5 Oral Antidiabetic Agents Key Players Head office and Area Served
3.6 Key Players Oral Antidiabetic Agents Product Solution and Service
3.7 Date of Enter into Oral Antidiabetic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic Agents Breakdown Data by Type
4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2019-2024)
4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030)
5 Oral Antidiabetic Agents Breakdown Data by Application
5.1 Global Oral Antidiabetic Agents Historic Market Size by Application (2019-2024)
5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Antidiabetic Agents Market Size (2019-2030)
6.2 North America Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Antidiabetic Agents Market Size by Country (2019-2024)
6.4 North America Oral Antidiabetic Agents Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antidiabetic Agents Market Size (2019-2030)
7.2 Europe Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Antidiabetic Agents Market Size by Country (2019-2024)
7.4 Europe Oral Antidiabetic Agents Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic Agents Market Size (2019-2030)
8.2 Asia-Pacific Oral Antidiabetic Agents Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antidiabetic Agents Market Size (2019-2030)
9.2 Latin America Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024)
9.4 Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic Agents Market Size (2019-2030)
10.2 Middle East & Africa Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction
11.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.1.5 Novo Nordisk Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic Agents Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.2.5 Eli Lilly Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Oral Antidiabetic Agents Introduction
11.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Oral Antidiabetic Agents Introduction
11.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Oral Antidiabetic Agents Introduction
11.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.5.5 Teva Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Oral Antidiabetic Agents Introduction
11.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Wockhardt UK
11.7.1 Wockhardt UK Company Detail
11.7.2 Wockhardt UK Business Overview
11.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction
11.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.7.5 Wockhardt UK Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Agents Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Agents Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Cipla
11.10.1 Cipla Company Detail
11.10.2 Cipla Business Overview
11.10.3 Cipla Oral Antidiabetic Agents Introduction
11.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024)
11.10.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sulfonylureas
Table 3. Key Players of Meglitinides
Table 4. Key Players of Biguanides
Table 5. Key Players of Thiazolidinediones
Table 6. Key Players of Alpha-glucosidase Inhibitors
Table 7. Global Oral Antidiabetic Agents Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oral Antidiabetic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oral Antidiabetic Agents Market Share by Region (2019-2024)
Table 11. Global Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oral Antidiabetic Agents Market Share by Region (2025-2030)
Table 13. Oral Antidiabetic Agents Market Trends
Table 14. Oral Antidiabetic Agents Market Drivers
Table 15. Oral Antidiabetic Agents Market Challenges
Table 16. Oral Antidiabetic Agents Market Restraints
Table 17. Global Oral Antidiabetic Agents Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oral Antidiabetic Agents Market Share by Players (2019-2024)
Table 19. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)
Table 20. Ranking of Global Top Oral Antidiabetic Agents Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Oral Antidiabetic Agents Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Antidiabetic Agents Product Solution and Service
Table 24. Date of Enter into Oral Antidiabetic Agents Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oral Antidiabetic Agents Revenue Market Share by Type (2019-2024)
Table 28. Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oral Antidiabetic Agents Revenue Market Share by Type (2025-2030)
Table 30. Global Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oral Antidiabetic Agents Revenue Market Share by Application (2019-2024)
Table 32. Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oral Antidiabetic Agents Revenue Market Share by Application (2025-2030)
Table 34. North America Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Oral Antidiabetic Agents Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 49. Novo Nordisk Company Detail
Table 50. Novo Nordisk Business Overview
Table 51. Novo Nordisk Oral Antidiabetic Agents Product
Table 52. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 53. Novo Nordisk Recent Development
Table 54. Eli Lilly Company Detail
Table 55. Eli Lilly Business Overview
Table 56. Eli Lilly Oral Antidiabetic Agents Product
Table 57. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 58. Eli Lilly Recent Development
Table 59. Sanofi Company Detail
Table 60. Sanofi Business Overview
Table 61. Sanofi Oral Antidiabetic Agents Product
Table 62. Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche Oral Antidiabetic Agents Product
Table 67. Roche Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Teva Company Detail
Table 70. Teva Business Overview
Table 71. Teva Oral Antidiabetic Agents Product
Table 72. Teva Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 73. Teva Recent Development
Table 74. AstraZeneca Company Detail
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Oral Antidiabetic Agents Product
Table 77. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 78. AstraZeneca Recent Development
Table 79. Wockhardt UK Company Detail
Table 80. Wockhardt UK Business Overview
Table 81. Wockhardt UK Oral Antidiabetic Agents Product
Table 82. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 83. Wockhardt UK Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Oral Antidiabetic Agents Product
Table 87. Merck Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Pfizer Company Detail
Table 90. Pfizer Business Overview
Table 91. Pfizer Oral Antidiabetic Agents Product
Table 92. Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Cipla Company Detail
Table 95. Cipla Business Overview
Table 96. Cipla Oral Antidiabetic Agents Product
Table 97. Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)
Table 98. Cipla Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic Agents Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oral Antidiabetic Agents Market Share by Type: 2023 VS 2030
Figure 3. Sulfonylureas Features
Figure 4. Meglitinides Features
Figure 5. Biguanides Features
Figure 6. Thiazolidinediones Features
Figure 7. Alpha-glucosidase Inhibitors Features
Figure 8. Global Oral Antidiabetic Agents Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Oral Antidiabetic Agents Market Share by Application: 2023 VS 2030
Figure 10. Home Use Case Studies
Figure 11. Medical Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Oral Antidiabetic Agents Report Years Considered
Figure 14. Global Oral Antidiabetic Agents Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Oral Antidiabetic Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oral Antidiabetic Agents Market Share by Region: 2023 VS 2030
Figure 17. Global Oral Antidiabetic Agents Market Share by Players in 2023
Figure 18. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2023
Figure 20. North America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 22. United States Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 26. Germany Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Oral Antidiabetic Agents Market Share by Region (2019-2030)
Figure 34. China Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 42. Mexico Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Oral Antidiabetic Agents Market Share by Country (2019-2030)
Figure 46. Turkey Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 49. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 50. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 52. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 54. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 56. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 57. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
